- Presentations
- 3
- Markets
- 1
Sogroya is a brand of Somapacitan marketed by Novo Nordisk, with 3 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Somapacitan
- Brand owner
- Novo Nordisk
- Registered in
- United States
- Strengths and forms
- 10.05 mg/1.5 mL injection, 15 mg/1.5 mL injection, 4.95 mg/1.5 mL injection
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sogroya 10.05 mg/1.5 mL injectionSubcutaneous Cold chain | Novo Nordisk | US FDA | Available on request |
| Sogroya 15 mg/1.5 mL injectionSubcutaneous Cold chain | Novo Nordisk | US FDA | Available on request |
| Sogroya 4.95 mg/1.5 mL injectionSubcutaneous Cold chain | Novo Nordisk | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Sogroya
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.